Cook launches new sizes of peripheral DES
This article was originally published in Clinica
Executive Summary
Cook Medical has launched new sizes of its Zilver PTX drug-eluting peripheral stent, designed to treat peripheral artery disease in the superficial femoral artery, in Europe. The paclitaxel-coated device will now be available in lengths up to 120mm and with a 6 French diameter delivery system. Recently clinical data showed that the device causes a 50% reduction in restenosis compared with bare-metal stenting and allows 74.8% primary patency at two years (www.clinica.co.uk, 18 January 2011). Andy Förster, EMEA manager for Cook's peripheral intervention business unit, said: "Since the announcement of this data, adoption of the Zilver PTX has greatly increased." Zilver PTX is not yet approved in the US.
You may also be interested in...
Normality Reasserts Itself For Biotech IPOs
The highs of the COVID-19 era, and the lows that supplanted it, are beginning to fade.
MRM Health Pulls A Pouchitis Hit Out Of The Bag
The mid-stage success is encouraging, but taking on Takeda won’t be easy.
Novartis Draws Out Its APPLAUSE
Another data drop from Fabhalta’s IgAN trial looks encouraging, despite a missing abstract.